4.5 Article

Pallidal dopaminergic denervation and rest tremor in early Parkinson's disease: PPMI cohort analysis

Journal

PARKINSONISM & RELATED DISORDERS
Volume 51, Issue -, Pages 101-104

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.parkreldis.2018.02.039

Keywords

Rest tremor; Globus pallidus; Dopamine transporter; SPECT; Parkinson's disease

Funding

  1. Michael J. Fox Foundation for Parkinson's Research
  2. AbbVie
  3. Avid
  4. Biogen
  5. Bristol-Myers Squibb
  6. General Electric Healthcare
  7. BioLegend
  8. Genentech
  9. GlaxoSmithKline
  10. Lilly
  11. Lundbeck
  12. Merck
  13. Meso Sale Discovery
  14. Pfizer
  15. Piramal
  16. Roche
  17. Sanofi Genzyme
  18. Servier
  19. Takeda
  20. TEVA
  21. Union Chimique Belge
  22. GOLUB CAPITAL

Ask authors/readers for more resources

Background: s: Over recent years there have been some conflicting reports upon the role of pallidal dopaminergic denervation in rest tremor in Parkinson's disease. Objectives: To clarify this issue we analyzed the clinical and 1231-FP-CIT SPECT data of a large cohort of early Parkinson's disease patients enrolled in the PPMI study. Methods: Pallidal and striatal dopamine transporter uptake ratios were calculated in 382 patients (120 no-tremor, 60 tremor-dominant, and 202 indeterminate) and 150 controls. A region of interest (ROI) approach was used to estimate DAT uptake ratios from 1231-FP-CIT SPECT scans in the caudate nucleus, putamen, and globus pallidus after normalization to a DAT template. DAT uptake ratios for each region were compared between subgroups using ANCOVA and linear regression analyses were performed to evaluate the relationship between severity of rest tremor and regional DAT uptake ratios. Results: PD patients had significantly lower DAT uptake ratios in the pallidum, putamen and caudate as compared to healthy controls (p < 0.001). ANCOVA showed inter-PD subgroup differences in DAT uptake ratios in the putamen and pallidum (p <0.05) after adjustment for age and disease duration, with posthoc comparisons revealing significantly higher DAT uptake ratios for the tremor-dominant subgroup as compared to non-tremor and indeterminate subgroups (p < 0.016). There was no significant relationship between rest tremor severity and pallidal DAT either in the tremor-dominant subgroup or in the total PD population. Conclusions: Pallidal dopaminergic denervation appears unrelated to rest tremor severity in early Parkinson's disease. (C) 2018 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available